1,132
Views
18
CrossRef citations to date
0
Altmetric
Original Articles

A case example of a radiation-relevant adverse outcome pathway to lung cancer

ORCID Icon, , , &
Pages 68-84 | Received 17 Oct 2019, Accepted 06 Dec 2019, Published online: 09 Jan 2020

References

  • Amundson SA, Chen DJ. 1996. Ionizing radiation-induced mutation of human cells with different DNA repair capacities. Adv Space Res. 18(1–2):119–26.
  • Anderson CW. 1993. DNA damage and the DNA-activated protein kinase. Trends Biochem Sci. 18(11):433–437.
  • Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, et al. 2010. Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem. 29(3):730–741.
  • Antonelli AF, Campa A, Esposito G, Giardullo P, Belli M, Dini V, Meschini S, Simone G, Sorrentino E, Gerardi S, et al. 2015. Induction and repair of DNA DSB as revealed by H2AX phosphorylation foci in human fibroblasts exposed to low- and high-LET radiation : relationship with early and delayed reproductive cell death induction and repair of DNA DSB as revealed by H2AX phosphor. Radiat Res. 183(4):417–431.
  • Arlt MF, Rajendran S, Birkeland SR, Wilson TE, Glover TW. 2013. Copy number variants are produced in response to low-dose ionizing radiation in cultured cells. Envrion Mol Mutagen. 55(2):103–113.
  • Asaithamby A, Chen DJ. 2009. Cellular responses to DNA double-strand breaks after low-dose c -irradiation. Nucleic Acids Res. 37(12):3912–3923.
  • Balajee AS, Bertucci A, Taveras M, Brenner D. 2014. Multicolour FISH analysis of ionising radiation-induced micronucleus formation in human lymphocytes. Mutagenesis. 29(6):447–455.
  • Barron CC, Moore J, Tsakiridis T, Pickering G, Tsiani E. 2014. Inhibition of human lung cancer cell proliferation and survival by wine. Cancer Cell Int. 14(1):6.
  • Beels L, Bacher K, De Wolf D, Werbrouck J, Thierens H. 2009. Gamma-H2AX foci as a biomarker for patient X-ray exposure in pediatric cardiac catheterization: are we underestimating radiation risks? Circulation. 120(19): 1903–1909.
  • Betermier M, Bertrand P, Lopez BS. 2014. Is non-homologous end-joining really an inherently error-prone process? PLoS Genet. 10(1):e1004086.
  • Boss MK, Bristow R, Dewhirst MW. 2014. Linking the history of radiation biology to the hallmarks of cancer. Radiat Res. 181(6):561–577.
  • Bracalente C, Ibañez IL, Molinari B, Palmieri M, Kreiner A, Valda A, Davidson J, Durán H. 2013. Induction and persistence of large g H2AX foci by high linear energy transfer radiation in DNA-dependent protein kinase e deficient cells. Int J Radiat Oncol Biol Phys. 87(4):785–794.
  • Chang HHY, Pannunzio NR, Adachi N, Lieber MR. 2017. Non-homologous DNA end joining and alternative pathways to double – strand break repair. Nat Rev Mol Cell Biol. 18(8):495–506.
  • Charlton DE, Nikjoo HH, Humm JL. 1989. Calculation of initial yields of single- and double-strand breaks in cell nuclei from electrons, protons and alpha particles. Int J Radiat Biol. 56(1):1–19.
  • Chauhan V, Said Z, Daka J, Sadi B, Bijlani D, Marchetti F, Beaton D, Gaw A, Li C, Burtt J, et al. 2019. Is there a role for the adverse outcome pathway framework to support radiation protection? Int J Radiat Biol. 95(2):225–232.
  • Chernikova SB, Wells RL, Elkind MM. 1999. Wortmannin sensitizes mammalian cells to radiation by inhibiting the dna-dependent protein kinase-mediated rejoining of double-strand breaks. Radiat Res. 151(2):159–166.
  • Cornforth M, Bedford J. 1985. On the nature of a defect in cells from individuals with ataxia-telangiectasia. Science. 227(4694):1589–1591.
  • Cortot AB, Younes M, Martel-Planche G, Guibert B, Isaac S, Souquet PJ, Commo F, Girard P, Fouret P, Brambilla E, et al. 2014. Mutation of TP53 and alteration of p14(arf) expression in EGFR- and KRAS-mutated lung adenocarcinomas. Clin Lung Cancer. 15(2):124–130.
  • Cory S. 1986. Activation of cellular oncogenes in hemopoietic cells by chromosome Translocation Review. Adv Cancer Res. 47:189–234.
  • de Lara CM, Hill MA, Jenner TJ, Papworth D, O'Neill P. 2001. Dependence of the yield of DNA double-strand breaks in Chinese hamster V79-4 cells on the photon energy of ultrasoft X rays. Radiat Res. 155(3):440–448.
  • Desouky O, Ding N, Zhou G. 2015. Targeted and non-targeted effects of ionizing radiation. J Radiat Res Appl Sci. 8(2):247–254.
  • Dikomey E, Brammer I. 2000. Relationship between cellular radiosensitivity and non-repaired double-strand breaks studied for di Ú erent growth states, dose rates and plating conditions in a normal human broblast line. Int J Radiat Biol. 76(6):773–781.
  • Dong J, Zhang T, Ren Y, Wang Z, Ling CC, He F, Li GC, Wang C, Wen B. 2017. Inhibiting DNA-PKcs in a non-homologous end-joining pathway in response to DNA double-strand breaks. Oncotarget. 8(14):22662–22673.
  • Duan W, Gao L, Jin D, Otterson GA, Villalona-Calero MA. 2008. Lung specific expression of a human mutant p53 affects cell proliferation in transgenic mice. Transgenic Res. 17(3):355–366.
  • Eymin B, Gazzeri S. 2010. Role of cell cycle regulators in lung carcinogenesis. Cell Adhes Migrations. 4(1):114–123.
  • Egawa H, Furukawa K, Preston D, Funamoto S, Yonehara S, Matsuo T, Tokuoka S, Suyama A, Ozasa K, Kodama K, et al. 2012. Radiation and smoking effects on lung cancer incidence by histological types among atomic bomb survivors. Radiat Res. 178(3):191–201.
  • Fedak KM, Bernal A, Capshaw ZA, Gross S. 2015. Applying the Bradford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol. 12(1):14.
  • Feldmann E, Schmiemann V, Goedecke W, Reichenberger S, Pfeiffer P. 2000. DNA double-strand break repair in cell-free extracts from Ku80-deficient cells : implications for Ku serving as an alignment factor in non-homologous DNA end joining. Nucleic Acids Res. 28(13):2585–2596.
  • Fernandez-Antoran D, Piedrafita G, Murai K, Ong SH, Herms A, Frezza C, Jones PH. 2019. Outcompeting p53-mutant cells in the normal esophagus by redox manipulation. Cell Stem Cell. 25(3):329–341.e6.
  • Flegal M, Blimkie MS, Wyatt H, Bugden M, Surette J, Klokov D. 2015. Measuring DNA damage and repair in mouse splenocytes after chronic in vivo exposure to very low doses of beta- and gamma-radiation. J Vis Exp. 3:e52912.
  • Fowlis DJ, Balmain A. 1993. Oncogenes and tumour suppressor genes in transgenic mouse models of neoplasia. Eur J Cancer. 29(4):638–645.
  • Galloway MS. 1995. A role for mismatch repair in production of chromosome aberrations by methylating agents in human cells. Mutat Res. 346:231–245.
  • Gaymes TJ, Mufti GJ, Rassool FV. 2002. Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimer. Cancer Res. 62(10):2791–2797.
  • Geng C, Kaochar S, Li M, Rajapakshe K, Fiskus W, Dong J, Foley C, Dong B, Zhang L, Kown O-J, et al. 2017. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein. Oncogene. 36:4767–4777.
  • Getts RC, Stamato TD. 1994. Absence of a Ku-like DNA end binding activity in the xrs double-strand DNA repair-deficient mutant. J Biol Chem. 269(23):15981–15984.
  • George KA, Hada M, Jackson LJ, Elliott T, Kawata T, Pluth JM, Cucinotta FA. 2009. Dose response of gamma rays and iron nuclei for induction of chromosomal aberrations in normal and repair-deficient cell lines. Radiat Res. 171(6):752–763.
  • Ghezraoui H, Piganeau M, Renouf B, Renaud JB, Sallmyr A, Ruis B, Oh S, Tomkinson AE, Hendrickson EA, Giovannangeli C, et al. 2014. Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining. Mol Cell. 55(6):829–842.
  • Godwin AR, Bollag RJ, Christie DM, Liskay RM. 1994. Spontaneous and restriction enzyme-induced chromosomal recombination in mammalian cells. Proc Natl Acad Sci. 91(26):12554–12558.
  • Goodhead DT. 2006. Energy deposition stochastics and track structure: what about the target? Radiat Prot Dosimetry. 122(1–4):3–15.
  • Gostissa M, Ranganath S, Bianco JM, Alt FW. 2009. Chromosomal location targets different MYC family gene members for oncogenic translocations. Proc Natl Acad Sci USA. 106(7):2265–2270.
  • Gradowski JF, Mantha GS, Hunt JL, Dacic S. 2007. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs. Diagn Mol Pathol. 16(2):87–90.
  • Grudzenski S, Raths A, Conrad S, Rube CE, Lobrich M. 2010. Inducible response required for repair of low-dose radiation damage in human fibroblasts. Proc Natl Acad Sci USA. 107(32):14205–14210.
  • Guamerio J, Bezzi M, Jeong JC, Paffenholz SV, Berry K, Naldini MM, Lo-Coco F, Tay Y, Beck AH, Pandolfi PP. 2016. Oncogenic role of fusion-circRNAs derived from cancer-associated chromosomal translocations. Cell. 165(2):289–302.
  • Guirouilh-Barbat J, Rass E, Plo I, Bertrand P, Lopez BS. 2007. Defects in XRCC4 and KU80 differentially affect the joining of distal nonhomologous ends. Proc Natl Acad Sci USA. 104(52):20902–20907.
  • Hada M, Georgakilas AG. 2008. Formation of clustered DNA damage after high-LET irradiation: a review. J Radiat Res. 49(3):203–210.
  • Hirsch FA, Paulson OB, Hansen HH, Vraa-Jensen J. 1982. Intracranial metastases in small cell carcinoma of the lung: correlation of clinical and autopsy findings. Cancer. 50(11):2433–2437.
  • Hoeijmakers JH. 2001. Genome maintenance mechanisms for preventing cancer. Nature. 411(6835):366–374.
  • Hoel DG, Haseman JK, Hogan MD, Huff J, McConnell EE. 1988. The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis. 9(11):2045–2052.
  • Hubaux R, Becker-Santos DD, Enfield KS, Lam S, Lam WL, Martinez VD. 2012. Arsenic, asbestos and radon: emerging players in lung tumorigenesis. Environ Health. 11(1):89.
  • Hundley JE, Koester SK, Troyer DA, Hilsenbeck SG, Subler MA, Windle JJ. 1997. Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53. Mol Cell Biol. 17(2):723–731.
  • Iliakis G. 1991. The role of DNA double strand breaks in ionizing radiation-induced killing of eukaryotic cells. BioEssays. 13:641–648.
  • Irwin ME, Nelson LD, Santiago-O’Farrill JM, Knouse PD, Miller CP, Palla SL, Siwak DR, Mills GB, Estrov Z, Li S, et al. 2013. Small molecule ErbB inhibitors decrease proliferative signalling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemia. PLOS One. 8(8):e70608.
  • Janssen A, van der Burg M, Szuhai K, Kops GJPL, Medema RH. 2011. Chromosomal segregation errors cause of DNA damage and structural chromosomal aberrations. Science. 333(6051):1895–1898.
  • Jarvis EM, Kirk JA, Clarke CL. 1998. Loss of nuclear BRCA1 expression in breast cancers is associated with a highly proliferative tumor phenotype. Cancer Genet Cytogenet. 101(2):109–115.
  • Jeggo P. A, Lobrich M. 2015. How cancer cells hijack DNA double-strand break repair pathways to gain genomic instability. Biochem J. 471(1):1–11.
  • Jeggo PA. 1998. 5 DNA breakage and repair. Adv Gen. 38:185–218.
  • Joiner MC, Van Der Kogel A. 2009. Basic clinical radiobiology. 4th ed. London, UK: Hodder Arnold.
  • Kaczmarska M, Żydek D, Wilkłacz-Potoczny J, Fornal M, Grodzicki T, Kochowska E, Kozak K, Gocal Ł, Pohorecki W, Matlak K, et al. 2017. The influence of very small doses of alpha radiation on the stability of erythrocytes. Microsc Res Tech. 80(1):131–143.
  • Karanjawala ZE, Grawunder U, Hsieh CL, Lieber MR. 1999. The non-homologous DNA end joining pathway is important for chromosome stability in primary fibrobalasts. Curr Biol. 9(24):1501–1504.
  • Kassie F, Matise I, Negia M, Upadhyaya P, Hecht SS. 2008. Dose-dependent inhibition of tobacco smoke carcinogen-induced lung tumorigenesis in A/J mice by indole-3-carbinol. Cancer Prev Res (Phila). 1(7):568–576.
  • Kelly K, Bunn PA. Jr. 1998. Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer? Lung Cancer. 20(2):85–91.
  • Kim HR, Shim HS, Chung JH, Lee YJ, Hong YK, Rha SY, Kim SH, Ha SJ, Kim SK, Chung KY, et al. 2012. Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement. Cancer. 118(3):729–739.
  • Kuefner MA, Grudzenski S, Schwab SA, Wiederseiner M, Heckmann M, Bautz W, Lobrich M, Uder M. 2009. DNA double-strand breaks and their repair in blood lymphocytes of patients undergoing angiographic procedures. Investigat Radiol. 44(8):440–446.
  • Kuhne M, Urban G, Frankenberg D, Löbrich M. 2005. DNA double-strand break misrejoining after exposure of primary human fibroblasts to CK characteristic X rays, 29 kVp X rays and 60Co g rays. Radiat Res. 164:669–676.
  • Kurgan N, Tsakiridis E, Kouvelioti R, Moore J, Klentrou P, Tsiani E. 2017. Inhibition of human lung cancer cell proliferation and survival by post-exercise serum is associated with the inhibition of Akt, mTOR, p70 S6K, and Erk1/2. Cancers. 9(5)pii:E46.
  • Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM, Valentin-Vega YA, Terzian T, Caldwell LC, Strong LC, et al. 2004. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell. 119(6):861–872.
  • Leibowitz ML, Zhang C, Pellman D. 2015. Chromothripsis: a new mechanism for rapid karyotype evolution. Annu Rev Genet. 49:183–211.
  • Li H, Ma XY, Wang J, Koontz J, Nucci M, Sklar J. 2007. Effects of rearrangement and allelic exclusion of JJAZ1/SUZ12 on cell proliferation and survival. PNAS. 104(50):20001–20006.
  • Li Z, Xiong Y. 2017. Cytoplasmic E3 ubiquitin ligase CUL9 controls proliferation, senescence, apoptosis and genome integrity through p53. Oncogene. 36(36):5212–5218.
  • Lieber MR, Ma Y, Pannicke U, Schwarz K. 2003. Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol. 4(9):712–720.
  • Lieber MR, Gu J, Lu H, Shimazaki N, Tsai AG. 2010. Nonhomologous DNA end joining (NHEJ) and chromosomal translocations in humans. Subcell Biochem. 50:279–296.
  • Lim EH, Zhang SL, Li JL, Yap WS, Howe TC, Tan BP, Lee YS, Wong D, Khoo KL, Seto KY, et al. 2009. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). J Thorac Oncol. 4(1):12–21.
  • Lin YF, Nagasawa H, Little JB, Kato TA, Shih HY, Xie XJ, Wilson Jr PF, Brogan JR, Kurimasa A, Chen DJ, et al. 2014. Differential radiosensitivity phenotypes of DNA-PKcs mutations affecting NHEJ and HRR systems following irradiation with gamma-rays or very low fluences of alpha particles. PLoS One. 9(4):e93579.
  • Little JB. 2000. Radiation carcinogenesis. J Toxicol Environ Health. 6(5–6):51–56.
  • Liu M, Cai X, Yu W, Lv C, Fu X. 2015. Clinical significance of age at diagnosis among young non-small cell lung cancer patients under 40 years old: a population-based study. Oncotarget. 6(42):44963–44970.
  • Lloyd SM, Lopez M, El-Zein R. 2013. Cytokinesis-blocked micronucleus cytome assay and spectral karyotyping as methods for identifying chromosome damage in a lung cancer case-control population. Genes Chromosomes Cancer. 52(7):694–707.
  • Lobrich M, Kühne M, Wetzel J, Rothkamm K. 2000. Joining of correct and incorrect DNA double-strand break ends in normal human and ataxia telangiectasia fibroblasts. Genes Chromosomes Cancer. 68:59–68.
  • Lomax ME, Folkes LK, O'Neill P. 2013. Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. Clin Oncol. 25(10):578–585.
  • Lv T, Yuan D, Miao X, Lv Y, Zhan P, Shen X, Song Y. 2012. Over-expression of LSD1 promotes proliferation, migration and invasion in non-small cell lung cancer. PLOS One. 7(4):e35065.
  • Mao Z, Bozzella M, Seluanov A, Gorbunova V. 2008. DNA repair by nonhomologous end joining and homologous recombination during cell cycle in human cells. Cell Cycle. 7(18):2902–2906.
  • Mcmahon SJ, Scheumann J, Paganetti H, Prise KM. 2016. Mechanistic modelling of DNA repair and cellular survival following radiation-induced DNA damage. Sci Rep. 6:33290.
  • Mes-Masson A, Witte N. O. 1987. Role of the abl oncogene in chronic myelogenous leukemia. Adv Cancer Res. 49:53–74.
  • Minina VI, Soboleva OA, Glushkov AN, Voronina EN, Sokolova EA, Bakanova ML, Savchenko YA, Ryzhkova AV, Titov RA, Druzhinin VG, et al. 2017. Polymorphisms of GSTM1, GSTT1, GSTP1 genes and chromosomal aberrations in lung cancer patients. J Cancer Res Clin Oncol. 143(11):2235–2243.
  • Mitelman F. 2005. Cancer cytogenetics. Atlas of Genetics and Cytogenetics in Oncology and Haematology. 2:342–346.
  • Mosconi M, Giesen U, Langner F, Mielke C, Dalla Rosa I, Dirks WG. 2011. 53BP1 and MDC1 foci formation in HT-1080 cells for low- and high-LET microbeam irradiations. Radiat Envrion Biophys. 50(3):345–352.
  • Nikjoo H, Munson JR, Bridges AB. 1999. RBE-LET relationships in mutagenesis by ionizing radiation. J Radiat Res. 40(Suppl):85–105.
  • OECD. 2018a. Revised guidance document on developing and assessing adverse outcome pathways. Available from: http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=ENV/JM/MONO%282013%296&doclanguage=en.
  • OECD 2018b. Users' Handbook supplement to the Guidance Document for developing and assessing Adverse Outcome Pathways, OECD Series on Adverse Outcome Pathways. Paris: OECD Publishing.
  • Paik PK, Johnson ML, D'Angelo SP, Sima CS, Ang D, Dogan S, Miller VA, Ladanyi M, Kris MG, Riely GJ, et al. 2012. Driver mutations determine survival in smokers and never-smokers with stage IIIB/IV lung adenocarcinomas. Cancer. 118(23):5840–5847.
  • Pal HC, Sharma S, Strickland LR, Agarwal J, Athar M, Elmets CA, Afaq F. 2013. Delphinidin reduces cell proliferation and induces apoptosis of non-small-cell lung cancer cells by targeting EGFR/VEGFR2 signalling pathways. PLOS One. 8(10):e77270.
  • Pannunzio NR, Watanabe G, Lieber MR. 2018. Nonhomologous DNA end-joining for repair of DNA double-strand breaks. J Biol Chem. 293(27):10512–10523.
  • Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. 2000. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol. 10(15):886–895.
  • Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, Colledge WH, Friedman LS, Ponder BA, Venkitaraman AR. 1998. Involvement of Brca2 in DNA repair. Mol Cell. 1(3):347–357.
  • Perera D, Poulos RC, Shah A, Beck D, Pimanda JE, Wong JW. 2016. Differential DNA repair underlies mutation hotspots at active promoters in cancer genomes. Nature. 532(7598):259–263.
  • Petrini JHJ, Bressan DA, Yao MS. 1997. The RAD52 epistasis group in mammalian double strand break repair. Semin Immunol. 9(3):181–188.
  • Pfeiffer P, Goedecke W, Obe G. 2000. Mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. Annu Rev Genet. 47:433–455.
  • Pinto M, Prise K. 2005. Evidence for complexity at the nanometer scale of radiation-induced DNA DSBs as a determinant of rejoining kinetics evidence for complexity at the nanometer scale of radiation-induced DNA DSBs as a determinant of rejoining kinetics. Radiat Res. 164:73–85.
  • Povirk LF. 2006. Biochemical mechanisms of chromosomal translocations resulting from DNA double-strand breaks. DNA Repair. 5(9-10):1199–1212.
  • Ptacek O, Stavreva DA, Kim JK, Gichner T. 2001. Induction and repair of DNA damage as measured by the Comet assay and the yield of somatic mutations in gamma-irradiated tobacco seedlings. Mutat Res. 491(1–2):17–23.
  • Raabe OG. 2011. Toward improved ionizing radiation safety standards. Health Phys. 101(1):84–93.
  • Rassool FV, Tomkinson AE. 2010. Targeting abnormal DNA double strand break repair in cancer. Cell Mol Life Sci. 67(21):3699–3710.
  • Rathmell WK, Chu G. 1994. Involvement of the Ku autoantigen in the cellular response to DNA double-strand breaks. Proc Natl Acad Sci. 91(16):7623–7627.
  • Raynard S, Niu H, Sung P. 2017. DNA double-strand break processing: the beginning of the end. Genes Dev. 22:2903–2907.
  • Rode A, Maass KK, Willmund KV, Lichter P, Ernst A. 2016. Chromothripsis in cancer cells: an update. Int J Cancer. 138(10):2322–2333.
  • Rogakou EP, Boon C, Redon C, Bonner WM. 1999. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol. 146(5):905–916.
  • Rothkamm K, Kühne M, Jeggo PA, Löbrich M. 2001. Radiation-induced genomic rearrangements formed by nonhomologous end-joining of DNA double-strand breaks. Cancer Res. 61(10):3886–3893.
  • Rothkamm K, Lobrich M. 2003. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses. Proc Natl Acad Sci USA. 100(9):5057–5062.
  • Rube CE, Grudzenski S, Kühne M, Dong X, Rief N, Löbrich M, Rübe C. 2008. Cancer therapy : preclinical DNA double-strand break repair of blood lymphocytes and normal tissues analysed in a preclinical mouse model : implications for radiosensitivity testing. Clin Cancer Res. 14(20):6546–6556.
  • Rydberg B, Cooper B, Cooper PK, Holley WR, Chatterjee A. 2005. Dose-dependent misrejoining of radiation-induced DNA double-strand breaks in human fibroblasts : experimental and theoretical study for high- and low-LET radiation. Radiat Res. 534:526–534.
  • Samet JM, Eradze GR. 2000. Radon and lung cancer risk: taking stock at the millenium. Environ Health Perspect. 108(Suppl 4):635–641.
  • Samet JM. 2006. Residential radon and lung cancer: end of the story? J Toxicol Environ Health A. 69(7-8):527–531.
  • Sanders HR, Albitar M. 2010. Somatic mutations of signaling genes in non-small-cell lung cancer. Cancer Genet Cytogenet. 203(1):7–15.
  • Sato T, Morita M, Tanaka R, Inoue Y, Nomura M, Sakamoto Y, Miura K, Ito S, Sato I, Tanaka N, et al. 2017. Ex vivo model of non-small cell lung cancer using mouse lung epithelial cells. Oncol Lett. 14(6):6863–6868
  • Schabath MB, Welsh EA, Fulp WJ, Chen L, Terr JK, Thompson ZJ, Engel BE, Xie M, Berglund AE, Creelan BC, et al. 2016. Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma. Oncogene. 35(24):3209–3216.
  • Seki Y, Mizukami T, Kohno T. 2015. Molecular process producing oncogene fusion in lung cancer cells by illegitimate repair of DNA double-strand breaks. Biomolecules. 5(4):2464–2476.
  • Shelke S, Das B. 2015. Dose response and adaptive response of non-homologous end joining repair genes and proteins in resting human peripheral blood mononuclear cells exposed to gamma radiation. Mutagenesis. 30(3):365–379.
  • Shore RE, Beck HL, Boice JD, Caffrey EA, Davis S, Grogan HA, Mettler FA, Preston RJ, Till JE, Wakeford R, et al. 2018. Implications of recent epidemiologic studies for the linear nonthreshold model 879 and radiation protection. J Radiol Prot. 38(3):1217–1233.
  • Shrivastav M, De Haro LP, Nickoloff JA. 2008. Regulation of DNA double-strand break repair pathway choice. Cell Res. 18(1):134–147.
  • Simsek D, Jasin M. 2010. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation. Nat Struct Mol Biol. 17(4):410–416.
  • Sishc BJ, Davis AJ. 2017. The role of the core non-homologous end joining factors in carcinogenesis and cancer. Cancers. 9(7):pii: E81.
  • Smith J, Baldeyron C, De Oliveira I, Sala-Trepat M, Papadopoulo D. 2001. The influence of DNA double-strand break structure on end-joining in human cells. Nucleic Acids Res. 29(23):4783–4792.
  • Smith J, Riballo E, Kysela B, Baldeyron C, Manolis K, Masson C, Lieber MR, Papadopoulo D, Jeggo P. 2003. Impact of DNA ligase IV on the delity of end joining in human cells. Nucleic Acids Res. 31(8):2157–2167.
  • Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S-I, Watanabe H, Kurashina K, Hatanaka H, et al. 2007. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 448:561–566.
  • Stopper H, Schmitt E, Gregor C, Mueller SO, Fischer WH. 2003. Increased cell proliferation is associated with genomic instability: elevated micronuclei frequencies in estradiol-treated human ovarian cancer cells. Mutagenesis. 18(3):243–247.
  • Sudprasert WP, Navasumrit P, Ruchirawat M. 2006. Effects of low-dose gamma radiation on DNA damage, chromosomal aberration and expression of repair genes in human blood cells. Int J Hyg Environ Health. 209(6):503–511.
  • Sun Q, Shi R, Wang X, Li D, Wu H, Ren B. 2016. Overexpression of ZIC5 promotes proliferation in non-small cell lung cancer. Biochem Biophysi Res Commun. 479(3):502–509.
  • Sutherland BM, Bennett PV, Sidorkina O, Laval J. 2000. Clustered DNA damages induced in isolated DNA and in human cells by low doses of ionizing radiation. PNAS. 97(1):103–108.
  • Suto Y, Akiyama M, Noda T, Hirai M. 2015. Construction of a cytogenetic dose-response curve for low-dose range gamma-irradiation in human peripheral blood lymphocytes using three-color FISH. Mutat Res Genet Toxicol Envrion Mutagen. 794:32–38
  • Thomas P, Umegaki K, Fenech M. 2003. Nucleoplasmic bridges are a sensitive measure of chromosome rearrangement in the cytokinesis-block micronucleus assay. Mutagenesis. 18(2):187–194.
  • Thurtle-Schmidt DM, Lo TW. 2018. Molecular biology at the cutting edge: a review on CRISPR/CAS9 gene editing for undergraduates. Biochem Mol Biol Educ. 46(2):195–205.
  • Tu S, Zhang XL, Wan HF, Xia YQ, Liu ZQ, Yang XH, Wan FS. 2018. Effect of taurine on cell proliferation and apoptosis human lung cancer A549 cells. Oncology. 15(4):5473–5480.
  • Tucker JD, Cofield J, Matsumoto K, Ramsey MJ, Freeman DC. 2005. Persistence of chromosome aberrations following acute radiation: I, PAINT translocations, dicentrics, rings, fragments, and insertions. Envrion Mol Mutagen. 45(2–3):229–248.
  • van Gent DC, Hoeijmakers JHJ, Kanaar R. 2001. Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet. 2(3):196–206.
  • Varella-Garcia M. 2009. Chromosomal and genomic changes in lung cancer. Cell Adhesion Migration. 4(1):100–106.
  • Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L, Newman J, Reczek EE, Weissleder R, Jacks T. 2007. Restoration of p53 function leads to tumour regression in vivo. Nature. 445(7128):661–665.
  • Vogelstein B, Kinzler KW. 2004. Cancer genes and the pathways they control. Nat Med. 10(8):789–799.
  • Wang-Michelitsch J, Michelitsch MT. 2007. Cell transformation in tumor-development: a result of accumulation of Misrepairs of DNA through many generations of cells. UK: Department of Medicine, Addenbrooke's Hospital, University of Cambridge.
  • Ward JF. 1988. DNA damage produced by ionizing radiation in mammalian cells; identities, mechanisms of formation and repairability. Prog Nucleic Acid Res Mol Biol. 35:95–125.
  • Warin RF, Chen H, DN Soroka, Zhu Y, Sang S. 2014. Induction of lung cancer cell apoptosis through a p53 pathway by [6]-shogaol and its cysteine-conjugated metabolite M2. J Agric Food Chem. 62(6):1352–1362.
  • Weinstock DM, Richardson CA, Elliott B, Jasin M. 2006. Modeling oncogenic translocations: distinct roles for double-strand break repair pathways in translocation formation in mammalian cells. DNA Repair. 5(9–10):1065–1074.
  • Wessendorf P, Vijg J, Nussenzweig A, Digweed M. 2014. Mutation research/fundamental and molecular mechanisms of mutagenesis deficiency of the DNA repair protein nibrin increases the basal but not the radiation induced mutation frequency in vivo. Mutat Res. 769:11–16.
  • Wilhelm T, Magalou I, Barascu A, Técher H, Debatisse M, Lopez B. 2014. Spontaneous slow replication fork progression elicits mitosis alterations in homologous recombination-deficient mammalian cells. PNAS. 111(2):763–768.
  • Wistuba II, Behrens C, Milchgrub S, Bryant D, Hung J, Minna JD, Gazdar AF. 1999. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene. 18(3):643–650.
  • Yamaguchi H, Uchihori Y, Yasuda N, Takada M, Kitamura H. 2005. Estimation of yields of OH radicals in water irradiated by ionizing radiation. J Radiat Res. 46(3):333–341.
  • Zhong CY, Zhou YM, Douglas GC, Witschi H, Pinkerton KE. 2005. MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats. Carcinogenesis. 26(12):2187–2195.
  • Zhu C, Mills KD, Ferguson DO, Lee C, Manis J, Fleming J, Gao Y, Morton CC, Alt FW. 2002. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell. 109(7):811–821.